JP2020528274A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020528274A5 JP2020528274A5 JP2020502711A JP2020502711A JP2020528274A5 JP 2020528274 A5 JP2020528274 A5 JP 2020528274A5 JP 2020502711 A JP2020502711 A JP 2020502711A JP 2020502711 A JP2020502711 A JP 2020502711A JP 2020528274 A5 JP2020528274 A5 JP 2020528274A5
- Authority
- JP
- Japan
- Prior art keywords
- splicing variants
- subject
- expression level
- nr4a1
- biomarkers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762535419P | 2017-07-21 | 2017-07-21 | |
| US62/535,419 | 2017-07-21 | ||
| PCT/US2018/042712 WO2019018540A1 (en) | 2017-07-21 | 2018-07-18 | METHODS FOR DETECTION OF PLASMOCYTE DYSGLOBULINEMIA |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020528274A JP2020528274A (ja) | 2020-09-24 |
| JP2020528274A5 true JP2020528274A5 (enExample) | 2021-08-26 |
| JP7223741B2 JP7223741B2 (ja) | 2023-02-16 |
Family
ID=63244986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502711A Active JP7223741B2 (ja) | 2017-07-21 | 2018-07-18 | 形質細胞疾患の検出方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20190025311A1 (enExample) |
| EP (1) | EP3655553B1 (enExample) |
| JP (1) | JP7223741B2 (enExample) |
| KR (1) | KR102785072B1 (enExample) |
| CN (1) | CN111194356B (enExample) |
| AU (1) | AU2018304242B2 (enExample) |
| BR (1) | BR112020000791A2 (enExample) |
| DK (1) | DK3655553T3 (enExample) |
| ES (1) | ES2916450T3 (enExample) |
| IL (1) | IL271465B2 (enExample) |
| MX (1) | MX2020000785A (enExample) |
| PL (1) | PL3655553T3 (enExample) |
| WO (1) | WO2019018540A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020000791A2 (pt) | 2017-07-21 | 2020-07-21 | Liquid Biopsy Research LLC | métodos para detecção de discrasia de célula plasmática |
| EP4041886A1 (en) | 2019-10-10 | 2022-08-17 | Liquid Biopsy Research LLC | Compositions, methods and kits for biological sample and rna stabilization |
| CN111349705A (zh) * | 2020-03-18 | 2020-06-30 | 昆明医科大学 | circASXL1作为肺癌诊断标志物及其运用 |
| AU2021281287A1 (en) * | 2020-05-29 | 2023-01-19 | Bio-Techne Corporation | Use of microvesicle signature for the diagnosis and treatment of kidney transplant rejection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005512557A (ja) | 2001-11-07 | 2005-05-12 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ アーカンソー | 遺伝子発現プロファイリングに基づく多発性骨髄腫の診断、予後、および治療標的候補の同定 |
| JP2004313167A (ja) | 2003-02-24 | 2004-11-11 | Joji Inasawa | 薬剤耐性マーカーおよびその利用 |
| EP1766086A4 (en) * | 2004-05-21 | 2009-10-28 | Univ Arkansas | USE OF GENETIC EXPRESSION PROFILING TO PREVENT THE CHANCE OF SURVIVAL OF A PATIENT WITH CANCER |
| EP2687608B1 (en) | 2005-06-08 | 2017-02-08 | Millennium Pharmaceuticals, Inc. | Methods for the identification, assessment, and treatment of patients with cancer therapy |
| CN102361991A (zh) * | 2009-01-02 | 2012-02-22 | 阿肯色大学托管委员会 | 硼替佐米在预测多发性骨髓瘤患者生存率中的应用 |
| WO2011152884A2 (en) * | 2010-06-04 | 2011-12-08 | Board Of Trustees Of The University Of Arkansas | 14 gene signature distinguishes between multiple myeloma subtypes |
| WO2013155048A1 (en) * | 2012-04-10 | 2013-10-17 | University Of Utah Research Foundation | Compositions and methods for diagnosing and classifying multiple myeloma |
| BR112020000791A2 (pt) | 2017-07-21 | 2020-07-21 | Liquid Biopsy Research LLC | métodos para detecção de discrasia de célula plasmática |
-
2018
- 2018-07-18 BR BR112020000791-9A patent/BR112020000791A2/pt active Search and Examination
- 2018-07-18 US US16/039,041 patent/US20190025311A1/en not_active Abandoned
- 2018-07-18 CN CN201880061441.9A patent/CN111194356B/zh active Active
- 2018-07-18 AU AU2018304242A patent/AU2018304242B2/en active Active
- 2018-07-18 JP JP2020502711A patent/JP7223741B2/ja active Active
- 2018-07-18 MX MX2020000785A patent/MX2020000785A/es unknown
- 2018-07-18 PL PL18755985.1T patent/PL3655553T3/pl unknown
- 2018-07-18 EP EP18755985.1A patent/EP3655553B1/en active Active
- 2018-07-18 ES ES18755985T patent/ES2916450T3/es active Active
- 2018-07-18 KR KR1020207004033A patent/KR102785072B1/ko active Active
- 2018-07-18 WO PCT/US2018/042712 patent/WO2019018540A1/en not_active Ceased
- 2018-07-18 DK DK18755985.1T patent/DK3655553T3/da active
-
2019
- 2019-12-16 IL IL271465A patent/IL271465B2/en unknown
-
2021
- 2021-10-14 US US17/501,168 patent/US12366575B2/en active Active
-
2025
- 2025-06-13 US US19/238,168 patent/US20260118360A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108138222B (zh) | 表观遗传染色体相互作用 | |
| US20200407791A1 (en) | Tissue molecular signatures of kidney transplant rejections | |
| US12258633B2 (en) | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm | |
| JP6408380B2 (ja) | 癌を患うリスクのある被検体を診断するための方法およびキット | |
| CN105102636B (zh) | 用于检测和测定前列腺癌预后的组合物和方法 | |
| CA2889087C (en) | Diagnostic method for predicting response to tnf.alpha. inhibitor | |
| CA2957396A1 (en) | Method of determining pik3ca mutational status in a sample | |
| US10787709B2 (en) | Methods for diagnosing risk of renal allograft fibrosis and rejection | |
| US11814683B2 (en) | Methods and compositions for predicting chronic lung allograft dysfunction | |
| Wu et al. | Plasma microRNA signature of patients with IgA nephropathy | |
| JP2018524972A (ja) | 肺癌の診断または検出のための方法及び組成物 | |
| CN116287220B (zh) | 用于快速诊断川崎病的分子生物标志物和分析方法 | |
| JP2021514624A5 (enExample) | ||
| EP3825417A2 (en) | Tissue molecular signatures of kidney transplant rejections | |
| US20210010090A1 (en) | Method and system for predicting recurrence and non-recurrence of melanoma using sentinel lymph node biomarkers | |
| JP2025506444A (ja) | 微小残存病変の分析を使用した癌のモニタリングのためのシステムおよび方法 | |
| CN111194356B (zh) | 用于检测浆细胞恶病质的方法 | |
| CN108315410B (zh) | 一组评估早期流产风险的dna甲基化标志物、引物及其应用 | |
| WO2014197936A1 (en) | Biomarkers and use thereof in identification of b-cell lymphoproliferative disorders | |
| US11421277B2 (en) | Methods and compositions for predicting chronic lung allograft dysfunction | |
| CN110656169B (zh) | 心房颤动的诊断标志物 | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| JP2026510430A (ja) | がん診断モデルを開発する方法及びがん検出方法の開発におけるその使用 | |
| JP2020524524A5 (enExample) | ||
| US11685950B2 (en) | Method of diagnosing and treating acute rejection in kidney transplant patients |